6-O-METHYL-3-O-DECLADINOSYL-3-O-(PYRIDIN-4-YL)ACETYL-8A-AZA-8A-HOMOERYTHROMYCIN_A
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 7eWlXsUNo2u |
|---|---|
| InChI | InChI=1S/C37H61N3O11/c1-12-27-37(8,46)31(43)24(6)33(44)39-20(2)19-36(7,47-11)32(51-35-29(42)26(40(9)10)17-21(3)48-35)22(4)30(23(5)34(45)49-27)50-28(41)18-25-13-15-38-16-14-25/h13-16,20-24,26-27,29-32,35,42-43,46H,12,17-19H2,1-11H3,(H,39,44)/t20-,21-,22+,23-,24-,26+,27-,29-,30+,31-,32-,35+,36-,37-/m1/s1 |
| InChIKey | HUDKTOCUPJHJDK-UZSWFSKASA-N |
| Mol Weight | 723.9 g/mol |
| Molecular Formula | C37H61N3O11 |
| Exact Mass | 723.43061 g/mol |
| Enantiomer InChIKey | HUDKTOCUPJHJDK-FGZPOAGKSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
6-O-METHYL-3-O-DECLADINOSYL-3-O-PHENYLACETYL-8A-AZA-8A-HOMOERYTHROMYCIN_A
6-O-METHYL-3-O-DECLADINOSYL-3-O-(PYRIDIN-3-YL)ACETYL-8A-AZA-8A-HOMOERYTHROMYCIN_A
6-O-METHYL-3-O-DECLADINOSYL-3-O-(4-NITROPHENYL)ACETYL-8A-AZA-8A-HOMOERYTHROMYCIN_A
6-O-METHYL-3-O-DECLADINOSYL-3-O-(4-METHOXYPHENYL)ACETAL-8A-AZA-8A-HOMOERYTHROMYCIN_A
6-O-METHYL-3-O-DECLADINOSYL-3-O-(3-PHENYLPROPIONYL)8A-AZA-8A-HOMOERYTHROMYCIN_A
6-O-METHYL-3-O-DECLADINOSYL(4-PHENYLBUTYRYL)8A-AZA-8A-HOMOERYTHROMYCIN_A
6-O-METHYL-3-O-DECLADINOSYL-3-O-(PYRIDIN-4YL-SULFONYL)-ACETYL8A-AZA-8A-HOMOERYTHROMYCIN_A
6-O-METHYL-3-O-DECLADINOSYL-3-O-(4-NITROPHENYL)ACRYLOYL8A-AZA-8A-HOMOERYTHROMYCIN_A
6-O-ETHYL-3-O-DECLADINOSYL-3-O-(4-NITROPHENYL)ACETYL-8A-AZA-8A-HOMOERYTHROMYCIN_A
6-O-METHYL-3-O-DECLADINOSYL-3-O-(4-NITROPHENYLCARBOMOYL)8A-AZA-8A-HOMOERYTHROMYCIN_A
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Antibacterial Activity of Isomeric 15-Membered Azalides | The Journal of Antibiotics | 2006 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.